Biohaven Pharmaceuticals is a startup based in the United States, most recent round Series-c-plus, 1 tracked investor.
Based in the United States, Biohaven Pharmaceuticals is a startup. Its most recent tracked round is Series-c-plus. Brouky records 1 investor associated with the company.
Biohaven Pharmaceuticals is a clinical-stage biopharmaceutical company that discovers, develops, and commercializes therapies across neuroscience, immunology, obesity, and oncology. The company is known for migraine treatments including Nurtec ODT (rimegepant) and Zavzpret (zavegepant).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.